Thomas Catinazzo - 28 Oct 2025 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Role
Chief Financial Officer
Signature
/s/ Soo-Yeun Lim, as Attorney-in-Fact
Issuer symbol
RLAY
Transactions as of
28 Oct 2025
Net transactions value
-$157,931
Form type
4
Filing time
30 Oct 2025, 16:15:39 UTC
Previous filing
30 Jul 2025
Next filing
15 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Catinazzo Thomas Chief Financial Officer C/O RELAY THERAPEUTICS, INC., 60 HAMPSHIRE STREET, CAMBRIDGE /s/ Soo-Yeun Lim, as Attorney-in-Fact 30 Oct 2025 0001818261

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLAY Common Stock Sale $157,931 -21,664 -6.5% $7.29 313,631 28 Oct 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 48,115 shares of restricted stock units ("RSUs") on October 27, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
F2 Includes 110,008 shares underlying RSUs.

Remarks:

Exhibit 24 - Power of Attorney